How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 101–200 of 1,000
Effect of Bariatric Surgery on CKD Risk
Friedman, A. N., Wahed, A. S., Wang, J., Courcoulas, A. P., Dakin, G. F., Hinojosa, M. W., Kimmel, P. L., Mitchell, J. E., Pomp, A., Pories, W. J., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017060707 · Cited by 111
Lakshan, S., Jayanath, N. Y., Abeysekera, W. P. K. M., & Abeysekera, W. K. S. M. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2916914 · Cited by 109
“Although antidiabetic drugs and insulin regimes are very effective in managing diabetes mellitus still there is no permanent cure for this disease [11].”
Long-term (>10 Yrs) Outcome of the Laparoscopic Biliopancreatic Diversion With Duodenal Switch
Bolckmans, R., & HIMPENS, J. M. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001622 · Cited by 112
Ding, L., Fan, Y., Li, H., Zhang, Y., Qi, D., Tang, S., Cui, J., He, Q., Zhuo, C., & Liu, M. R. (2020) · Obesity Reviews · doi:10.1111/obr.13030 · Cited by 118
Kelly, J., Karlsen, M., & Steinke, G. (2020) · American Journal of Lifestyle Medicine · doi:10.1177/1559827620930962 · Cited by 97
Sundbom, M., Hedberg, J., Marsk, R., Boman, L., Bylund, A., Hedenbro, J., Laurenius, A., Lundegårdh, G., Möller, P., Olbers, T., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001920 · Cited by 116
The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control
Douros, J. D., Tong, J., & D’Alessio, D. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00183 · Cited by 106
Ikramuddin, S., Korner, J., Lee, W.-J., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Wang, Q., Jeffery, R. W., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2481 · Cited by 99
“HDL cholesterol (mg/dL) 42 (16) 46 (18) 51 (20) 53 (19) 7.”
BackgroundInfluentialEffects of bariatric surgery on diabetic nephropathy after 5 years of follow-up
Heneghan, H., Cetin, D. C., Navaneethan, S. D., Orzech, N., Brethauer, S. A., & Schauer, P. R. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.08.016 · Cited by 107
“Guidelines from the ADA and the National Kidney Foundation highlight the benefits of tight glycemic and blood pressure control, as well as inhibition of the renin-angiotensin system, in retarding the progression of diabetic nephropathy.”
InfluentialImplementing a low-carbohydrate, ketogenic diet to manage type 2 diabetes mellitus
Westman, E. C., Tondt, J., Maguire, E., & Yancy, W. S. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1523713 · Cited by 95
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Carroll, R. W., Stubbs, R. S., & Krebs, J. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1714001 · Cited by 100
Li, R., Liu, Y., Liu, H., & Li, J. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13140 · Cited by 106
Hsu, C.-C., Almulaifi, A., Chen, J.-C., Ser, K.-H., Chen, S.-C., Hsu, K.-C., Lee, Y.-C., & Lee, W.-J. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.2602 · Cited by 92
GLP-1 and Glucose Tolerance After Sleeve Gastrectomy in Morbidly Obese Subjects With Type 2 Diabetes
Jiménez, A., Mari, A., Casamitjana, R., Lacy, A., Ferrannini, E., & Vidal, J. (2014) · Diabetes · doi:10.2337/db14-0357 · Cited by 95
“Participants in study 1 (n = 23) were selected out of our series of T2DM patients who had undergone SG at least 2 years before study entry (n = 55), of whom 18 (33%), 31 (56%), and 6 (11%) presented with nonremission, remission, or relapse of T2DM, respectively (6,7).”
MethodPersistence of severe liver fibrosis despite substantial weight loss with bariatric surgery
Pais, R., Aron‐Wisnewsky, J., Bedossa, P., Ponnaiah, M., Oppert, J., Siksik, J., Genser, L., Charlotte, F., Thabut, D., Clement, K., et al. (2022) · Hepatology · doi:10.1002/hep.32358 · Cited by 95
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
Waldron-Lynch, F., & Herold, K. C. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3402 · Cited by 106
“Ideally, immunomodulatory therapy would induce prolonged remission from type 1 diabetes and achieve cur”
BackgroundBariatric surgery versus intensive medical therapy for diabetes.
Schauer, P. R., Bhatt, D. L., & Kashyap, S. (2014) · PubMed · doi:10.1056/nejmc1407393 · Cited by 35
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab585 · Cited by 92
“Although the previous consensus statement suggested dividing diabetes remission into partial and complete categories, using different glycemic thresholds (16), this distinction could introduce ambiguity affecting policy decisions related to insurance premiums, reimbursements, and coding of medical encounters.”
InfluentialSelf-citationSettineri, S., Frisone, F., Merlo, E. M., Geraci, D., & Martino, G. (2019) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s193752 · Cited by 104
Lee, W., Hur, K. Y., Lakadawala, M., Kasama, K., Wong, S. K., & Lee, Y.-C. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1740-2 · Cited by 98
Yu, H., Di, J., Bao, Y., Zhang, P., Zhang, L., Tu, Y., Han, X., & Jia, W. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.06.019 · Cited by 92
Stem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 93
Zechner, J. F., Mirshahi, U. L., Satapati, S., Berglund, E. D., Rossi, J., Scott, M. M., Still, C. D., Gerhard, G. S., Burgess, S. C., Mirshahi, T., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.11.022 · Cited by 83
Murphy, R., Clarke, M., Evennett, N. J., Robinson, S. J., Humphreys, M. L., Hammodat, H., Jones, B., Kim, D. D., Cutfield, R. G., Johnson, M. H., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2872-6 · Cited by 92
“5%), in both cases without glucose lowering therapy or ongoing procedures for at least 1 year [24].”
BackgroundNagi, D., Hambling, C., & Taylor, R. (2019) · British Journal of Diabetes · doi:10.15277/bjd.2019.221 · Cited by 83
“ADA has previously proposed (16) the terms:”
BackgroundLee, W., Chong, K., Chen, S., Zachariah, J., Ser, K., Lee, Y.-C., & Chen, J. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2120-5 · Cited by 87
Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery
Park, J. Y. (2018) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2018.27.4.213 · Cited by 87
Zhang, Y., Yang, Y., Huang, Q., Zhang, Q., Li, M., & Wu, Y. (2022) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.12608 · Cited by 96
Ceperuelo‐Mallafré, V., Llauradó, G., Keiran, N., Benaiges, E., Astiarraga, B., Martínez, L., Pellitero, S., González-Clemente, J. M., Rodríguez, A., Fernández‐Real, J. M., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0114 · Cited by 87
“rate of remission after surgery, we used Buse’s consensus criteria, considering complete type 2 diabetes remission if HbA1c was ,6% and fasting glucose was ,100 mg/dL, in the absence of pharmacologic therapy or ongoing procedures, for a duration of at least 1 year (32).”
MethodCho, J.-M., Kim, H. J., Menzo, E. L., Park, S. S., Szomstein, S., & Rosenthal, R. J. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.03.001 · Cited by 98
“[35] Buse JB, Caprio S, Cefalu WT, et al.”
BackgroundEnglish, W. J., & Williams, D. B. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.06.003 · Cited by 82
Julia, C., Ciangura, C., Capuron, L., Bouillot, J., Basdevant, A., Poitou, C., & Oppert, J. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.10.008 · Cited by 83
Beating type 2 diabetes into remission
McCombie, L., Leslie, W., Taylor, R., Kennon, B., Sattar, N., & Lean, M. E. J. (2017) · BMJ · doi:10.1136/bmj.j4030 · Cited by 81
Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery
Werling, M., Vincent, R. P., Cross, G. F., Marschall, H.-U., Fändriks, L., Lönroth, H., Taylor, D. R., Alaghband-Zadeh, J., Olbers, T., & Le Roux, C. W. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.833647 · Cited by 78
“Remission of type 2 diabetes mellitus (T2DM), as defined by the American Diabetes Associations, [3], occurs in approximately 40% of patients after Roux-en-Y gastric bypass (RYGB) surgery [4,5].”
BackgroundOutcomes of Omega Loop Gastric Bypass, 6-Years Experience of 1520 Cases
Taha, O., Abdelaal, M., Abozeid, M., Askalany, A., & Alaa, M. H. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2623-8 · Cited by 83
“One of the study limitations is the follow-up period of 3 years only and the prolonged diabetes remission based on the American Diabetes Association, and most published studies define it as a complete remission for more than 5 years [25, 30, 31, 70, 71].”
BackgroundLiu, S. Y., Wong, S. K., Lam, C. C., Yung, M. Y., Kong, A. P. S., & Ng, E. K. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1628-4 · Cited by 82
Aron‐Wisnewsky, J., & Clément, K. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0454-9 · Cited by 89
Adam, S., Azmi, S., Ho, J. H., Liu, Y., Ferdousi, M., Siahmansur, T., Kalteniece, A., Marshall, A., Dhage, S. S., Iqbal, Z., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05052-8 · Cited by 78
Homan, J., Boerboom, A. B., Aarts, E. O., Doğan, K., van Laarhoven, C. J. H. M., Janssen, I. M. C., & Berends, F. J. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3421-7 · Cited by 83
van Ommen, B., Wopereis, S., van Empelen, P., van Keulen, H. M., Otten, W., Kasteleyn, M. J., Molema, J. J. W., de Hoogh, I. M., Chavannes, N. H., Numans, M. E., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00381 · Cited by 95
“Although the definition of “cure,” “reversal,” or “remission” of type 2 diabetes has been a matter of debate (18), various lines of evidence have demonstrated that T2D is a reversible disease.”
Lee, W.-J., Chong, K., Chen, C.-Y., Chen, S. C., Lee, Y. C., Ser, K., & Chuang, L. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0401-6 · Cited by 82
“0% without the use of oral hypoglycemics or insulin [23].”
BackgroundRemission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction?
Tsilingiris, D., Koliaki, C. C., & Kokkinos, A. D. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173171 · Cited by 85
“Based on the above, the uniform application of the ADA remission criteria in future studies may attenuate this source of bias.”
BackgroundMethodInfluentialPredictors of Clinical Remission in Cats with Diabetes Mellitus
Zini, E., Häfner, M., Osto, M., Franchini, M., Ackermann, M., Lutz, T. A., & Reusch, C. E. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0598.x · Cited by 76
Casajoana, A., Pujol, J., de Gordejuela, A. G. R., Elvira, J., Virgili, N. M., de Oca, F. J., Durán, X., Fernández‐Veledo, S., Vendrell, J. J., & Vilarrasa, N. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2669-7 · Cited by 78
Ried‐Larsen, M., Johansen, M. Y., MacDonald, C. S., Hansen, K. B., Christensen, R., Wedell‐Neergaard, A., Pilmark, N. S., Langberg, H., Vaag, A. A., Pedersen, B. K., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13802 · Cited by 70
“Importantly, these targets should be maintained for at least 1 year.(17) Moreover, a lowering of fasting glucose or HbA1c alone or in absence of glucose-lowering medications may not appropriately reflect a decreased risk of complications.”
BackgroundMethodInfluentialLiu, S. Y., Wong, S. K., Lam, C. C., & Ng, E. K. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12575 · Cited by 75
Murphy, R., Plank, L. D., Clarke, M., Evennett, N. J., Tan, J., Kim, D. D. W., Cutfield, R. G., & Booth, M. (2022) · Diabetes Care · doi:10.2337/dc21-2498 · Cited by 82
“Trial Outcomes The primary outcome was a glycated hemoglobin A1c (HbA1c) level of <6% (42 mmol/mol) without any glucoselowering medications at 5 years as defined by American Diabetes Association criteria for complete remission of type 2 diabetes (15).”
MethodBilleter, A. T., Senft, J. D., Gotthardt, D. N., Knefeli, P., Nickel, F., Schulte, T., Fischer, L., Nawroth, P. P., Büchler, M. W., & Müller-Stich, B. P. (2015) · Obesity Surgery · doi:10.1007/s11695-015-2006-y · Cited by 77
Evaluation of Vitamin and Trace Element Requirements after Sleeve Gastrectomy at Long Term
Pellitero, S., Martínez-Cáceres, E. M., Puig, R., Leis, A., Zavala, R., Granada, M. L., Pastor, C., Moreno, P., Tarascó, J., & Puig‐Domingo, M. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2557-1 · Cited by 79
“Type 2 diabetes mellitus (T2DM) complete remission after surgery was defined in agreement to published criteria [23].”
BackgroundLong-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy
Abbatini, F., Capoccia, D., Casella, G., Soricelli, E., Leonetti, F., & Basso, N. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.09.003 · Cited by 78
Dietary strategies for remission of type 2 diabetes: A narrative review
Brown, A. C., McArdle, P., Taplin, J., Unwin, D., Unwin, J., Deakin, T., Wheatley, S. D., Murdoch, C., Malhotra, A., & Mellor, D. D. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12938 · Cited by 83
“Supporting this, a retrospective cohort study of people with T2DM receiving typical ADA care (including dietary advice) reported a 7-year cumulative incidence of partial remission of only 1.47%, and complete remission rate of just 0.14% (66).”
MethodInfluentialLeonetti, F., Capoccia, D., Coccia, F., Casella, G., Baglio, G., Paradiso, F., Abbatini, F., Iossa, A., Soricelli, E., & Basso, N. (2012) · Archives of Surgery · doi:10.1001/archsurg.2012.222 · Cited by 71
Management of Pregnant Women after Bariatric Surgery
Harreiter, J., Schindler, K., Bancher‐Todesca, D., Göbl, C. S., Langer, F. B., Prager, G., Gessl, A., Leutner, M., Ludvik, B. H., Luger, A., et al. (2018) · Journal of Obesity · doi:10.1155/2018/4587064 · Cited by 84
Rosenfeld, R. M., Kelly, J. H., Agarwal, M., Aspry, K., Barnett, T., Davis, B. C., Fields, D., Gaillard, T., Gulati, M., Guthrie, G. E., et al. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221087624 · Cited by 71
The importance of the biliopancreatic limb length in gastric bypass: A systematic review
Zorrilla-Núñez, L. F., Campbell, A., Giambartolomei, G., Menzo, E. L., Szomstein, S., & Rosenthal, R. J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.10.013 · Cited by 72
Purnell, J. Q., Dewey, E. N., Laferrère, B., Selzer, F., Flum, D. R., Mitchell, J. E., Pomp, A., Pories, W. J., Inge, T., Courcoulas, A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa849 · Cited by 66
Berman, M. A., Guthrie, N. L., Edwards, K. L., Appelbaum, K. J., Njike, V. Y., Eisenberg, D. M., & Katz, D. L. (2018) · JMIR Diabetes · doi:10.2196/diabetes.9591 · Cited by 67
“In addition, a meaningful percentage (28%, 22/97) of participants achieved an HbA1c value below the diabetic range, 23% (5/22) of whom reported no diabetic medication use, indicating potential for partial or complete remission of diabetes as defined by the American Diabetes Association consensus definition [35].”
BackgroundTang, Q., Sun, Z., Zhang, N., Xu, G., Song, P., Xu, L., & Tang, W. (2016) · Medicine · doi:10.1097/md.0000000000003522 · Cited by 69
“6 mmol/L for at least 1 year without any medical or surgical treatment.(23,24) The following variables were assessed as secondary outcomes: FPG, HbA1c, changes in bodyweight, BMI, abdominal circumference, plasma total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides.”
Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy for Remission of Type 2 Diabetes
Castellana, M., Procino, F., Biacchi, E., Zupo, R., Lampignano, L., Castellana, F., Sardone, R., Palermo, A., Cesareo, R., Trimboli, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa737 · Cited by 74
LSG vs MGB-OAGB—3 Year Follow-up Data: a Randomised Control Trial
Shivakumar, S., Tantia, O., Goyal, G., Chaudhuri, T., Khanna, S., Ahuja, A., Poddar, A., & Majumdar, K. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3255-3 · Cited by 69
Assessment of obesity beyond body mass index to determine benefit of treatment
Aasheim, E. T., Aylwin, S. J. B., Radhakrishnan, S. T., Sood, A. S., Jovanovic, A., Olbers, T., & le Roux, C. W. (2011) · Clinical Obesity · doi:10.1111/j.1758-8111.2011.00017.x · Cited by 67
“Although previous studies have often reported a high rate of ‘cure’ of diabetes after bariatric surgery, recent suggested definitions (22) recommend that patients can only be considered to be in remission of type 2 diabetes if they have a fasting glucose <5.”
BackgroundResultSeven Years of Mini-Gastric Bypass in Type II Diabetes Patients with a Body Mass Index <35 kg/m2
Kular, K. S., Manchanda, N., & Cheema, G. K. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1941-y · Cited by 70
Lent, M. R., Benotti, P. N., Mirshahi, T., Gerhard, G. S., Strodel, W. E., Petrick, A. T., Gabrielsen, J. D., Rolston, D. D., Still, C. D., Hirsch, A. G., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0519 · Cited by 67
“Diabetes remission was compared between RYGB and control patients with diabetes using the ADA criteria (25) for complete remission (HbA1c ,5.”
Yang, X., Zhou, J., Shao, H., Huang, B., Kang, X., Wu, R., Bian, F., Hu, M., & Liu, D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac661 · Cited by 77
Surgical Management of Obesity and the Relationship to Cardiovascular Disease
Vest, A. R., Heneghan, H. M., Schauer, P. R., & Young, J. B. (2013) · Circulation · doi:10.1161/circulationaha.112.103275 · Cited by 65
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications
Adams, T. D., Arterburn, D. E., Nathan, D. M., & Eckel, R. H. (2016) · Diabetes Care · doi:10.2337/dc16-0157 · Cited by 64
Risstad, H., Svanevik, M., Kristinsson, J. A., Hjelmesaeth, J. S., Aasheim, E. T., Hofsø, D., Søvik, T. T., Karlsen, T., Fagerland, M. W., Sandbu, R., et al. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.2798 · Cited by 72
SADI-S 250 vs Roux-en-Y Duodenal Switch (RY-DS): Results of 5-Year Observational Study
Yashkov, Y. I., Семеновна, Б. Н., Torres, A., Малыхина, А. И., & Бекузаров, Д. К. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05031-z · Cited by 67
Durrer, C. G., McKelvey, S., Singer, J., Batterham, A. M., Johnson, J. D., Gudmundson, K., Wortman, J., & Little, J. P. (2021) · Nature Communications · doi:10.1038/s41467-021-25667-4 · Cited by 70
Predictors of Long-Term Diabetes Remission After Metabolic Surgery
Lee, M. H., Lee, W., Chong, K., Chen, J., Ser, K., Lee, Y.-C., & Chen, S. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2808-1 · Cited by 67
“0 % for at least 1 year.(22) The individual components of glycemic control (levels of serum glucose, HbA1c levels) as well as body weight, waist circumference, blood pressure, and levels of total cholesterol, LDL, triglyceride, uric acid, AST, alanine transaminase (ALT), albumin, insulin, C-peptide, iron, calcium, and…”
BackgroundGLP-1: A Mediator of the Beneficial Metabolic Effects of Bariatric Surgery?
Manning, S., Pucci, A., & Batterham, R. L. (2015) · Physiology · doi:10.1152/physiol.00027.2014 · Cited by 63
Tharakan, G., Behary, P., Wewer Albrechtsen, N. J., Chahal, H., Kenkre, J., Miras, A. D., Ahmed, A. R., Holst, J. J., Bloom, S. R., & Tan, T. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0446 · Cited by 61
Lee, W., Almulaifi, A. M., Chong, K., Chen, S., Tsou, J. J., Ser, K., Lee, Y.-C., & Chen, J. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1603-0 · Cited by 68
“5 % without the use of hypoglycemic medication [13].”
BackgroundChondronikola, M., Harris, L. L. S., & Klein, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12527 · Cited by 61
Type 2 Diabetes Mellitus Trajectories and Associated Risks
Oh, W., Kim, E., Castro, M. R., Caraballo, P. J., Kumar, V., Steinbach, M. S., & Simon, G. J. (2016) · Big Data · doi:10.1089/big.2015.0029 · Cited by 63
Metabolic Surgery for Hypertension in Patients With Obesity
Pareek, M., Bhatt, D. L., Schiavon, C. A., & Schauer, P. R. (2019) · Circulation Research · doi:10.1161/circresaha.118.313320 · Cited by 64
Gutierrez‐Mariscal, F. M., Cardelo, M. P., de la Cruz, S., Alcala‐Diaz, J. F., Roncero‐Ramos, I., Guler, I., Vals‐Delgado, C., López‐Moreno, A., Luque, R. M., Delgado‐Lista, J., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901290 · Cited by 60
Circulating neurofilament is linked with morbid obesity, renal function, and brain density
Rebelos, E., Rissanen, E., Bucci, M., Jääskeläinen, O., Honka, M., Nummenmaa, L., Moriconi, D., Laurila, S., Salminen, P. T. P., Herukka, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11557-2 · Cited by 65
Progression of diabetic retinopathy after bariatric surgery
Murphy, R., Jiang, Y., Booth, M., Babor, R., MacCormick, A., Hammodat, H., Beban, G., Barnes, R. M., & Vincent, A. L. (2015) · Diabetic Medicine · doi:10.1111/dme.12727 · Cited by 58
Bariatric surgery: a best practice article
Neff, K. J. H., & le Roux, C. W. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200798 · Cited by 55
Svanevik, M., Lorentzen, J., Borgeraas, H., Sandbu, R., Seip, B., Medhus, A. W., Hertel, J. K., Kolotkin, R. L., Småstuen, M. C., Hofsø, D., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00127-4 · Cited by 59
Thereaux, J., Corigliano, N., Poitou, C., Oppert, J., Czernichow, S., & Bouillot, J. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.11.022 · Cited by 64
Luo, P., Yu, H., Zhao, X., Bao, Y., Hong, C. S., Zhang, P., Tu, Y., Yin, P., Gao, P., Wei, L., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00022 · Cited by 64
Systematic review of feline diabetic remission: Separating fact from opinion
Gostelow, R., Forcada, Y., Graves, T. K., Church, D. B., & Niessen, S. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.08.014 · Cited by 62
Yu, H., Ni, Y., Bao, Y., Zhang, P., Zhao, A., Chen, T., Xie, G., Tu, Y., Zhang, L., Su, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2884 · Cited by 58
Ugale, S. M., Gupta, N., Modi, K. D., Kota, S. K., Satwalekar, V., Naik, V., Swapna, M., & Kumar, K. H. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0089-y · Cited by 59
Steven, S., Carey, P. E., Small, P. K., & Taylor, R. (2015) · Diabetic Medicine · doi:10.1111/dme.12567 · Cited by 55
Amor, A. J., Jiménez, A., Moize, V. L., Ibarzábal, A., Flores, L., Lacy, A. M., & Vidal, J. (2013) · Surgical Endoscopy · doi:10.1007/s00464-012-2708-3 · Cited by 59
Chen, J., Hsu, N., Lee, W., Chen, S.-C., Ser, K., & Lee, Y.-C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.027 · Cited by 60
Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss
Pournaras, D. J., Aasheim, E. T., Bueter, M., Ahmed, A. R., Welbourn, R., Olbers, T., & le Roux, C. W. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.01.021 · Cited by 55
Ejarque, M., Guerrero-Pérez, F., de la Morena, N., Casajoana, A., Virgili, N., López-Urdiales, R., Maymó-Masip, E., Pujol Gebelli, J., Garcia Ruiz de Gordejuela, A., Perez-Maraver, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42770-1 · Cited by 53
Which criteria should be used to define type 2 diabetes remission after bariatric surgery?
Ramos-Levi, A. M., Cabrerizo, L., Matía, P., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. A. (2013) · BMC Surgery · doi:10.1186/1471-2482-13-8 · Cited by 52
“[1] proposed in 2009 a consensus definition of diabetes remission.”
BackgroundResultInfluentialBenaiges, D., Roux, J. A. F., Pedro‐Botet, J., Chillarón, J. J., Renard, M., Parri, A., Ramón, J. M., Pera, M., & Goday, A. (2013) · International Journal of Surgery · doi:10.1016/j.ijsu.2013.02.007 · Cited by 58
Torres, A., Rubio, M. Á., Ramos-Levi, A. M., & Sánchez-Pernaute, A. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0688-4 · Cited by 59
Haghparas, Z., Kordrostami, Z., Sorouri, M., Rajabzadeh, M., & Khalifeh, R. (2020) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0058-x · Cited by 53
Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms
Vetter, M. L., Ritter, S., Wadden, T. A., & Sarwer, D. B. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.4.200 · Cited by 54
Efficacy of Dietary and Supplementation Interventions for Individuals with Type 2 Diabetes
Lewgood, J., Oliveira, B., Korzepa, M., Forbes, S. C., Little, J. P., Breen, L., Bailie, R., & Candow, D. G. (2021) · Nutrients · doi:10.3390/nu13072378 · Cited by 57
Adherence to Low-Carbohydrate Diets in Patients with Diabetes: A Narrative Review
Kumar, N. K., Merrill, J. D., Carlson, S., German, J., & Yancy, W. S., Jr. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s292742 · Cited by 51
Debédat, J., Roy, T. L., Voland, L., Belda, E., Alili, R., Adriouch, S., Lassen, P. B., Kasahara, K., Hutchison, E. R., Genser, L., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2050635 · Cited by 51
Diabetes after Bariatric Surgery
Shah, A., & Laferrère, B. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.12.009 · Cited by 50
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.